Find policies, billing codes, payers, states, and providers
Loading...
Create a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsCreate a personalized view of the payer policy updates that matter to you and get notified when changes occur.
Start getting alertsFind policies, billing codes, payers, states, and providers
CPT 0002M: Algorithmic Liver Fibrosis, Steatosis, and ASH Score
Coming soon
CPT 0003M: Laboratory Multi‑Assay Algorithmic Score for Liver Fibrosis/NASH
Coming soon
CPT 0004M: Molecular Diagnostic Test for 53-SNP Progression Risk Score
Coming soon
CPT 0006M: AFP and 161-Gene mRNA Expression Profiling for Hepatocellular Carcinoma
Coming soon
CPT 0007M: mRNA 51-Gene Expression Profiling with Algorithmic Index
Coming soon
CPT 0011M: mRNA 12-Gene Expression and Algorithmic Prostate Cancer Risk Score
Coming soon
CPT 0012M: mRNA Gene Expression Profiling for Urothelial Cancer Risk
Coming soon
CPT 0013M: mRNA Gene Expression Profiling and Urothelial Carcinoma Recurrence Risk Score
Coming soon
CPT 0015M: 24‑Hour Urine 25‑Steroid Panel with Adrenal Risk Score
Coming soon
CPT 0016M: mRNA Expression Profiling of Bladder Tumor (219 Genes)
Coming soon
Showing 1–10 of 14
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.